Antibacterial Activity of Bismuth Oxide Nanoparticles Compared to Amikacin against <i>Acinetobacter baumannii</i> and <i>Staphylococcus aureus</i>

Jawad, Kareem H.; Marzoog, Thorria R.; Hasoon, Buthenia A.; Sulaiman, Ghassan M.; Jabir, Majid S.; Ahmed, Elsadig M.; Khalil, Khalil A. A.

doi:https://doi.org/10.1155/2022/8511601

Journal of Nanomaterials

On this page

Abstract Introduction Materials and Methods Results and Discussion Conclusions Data Availability Conflicts of Interest Acknowledgments References Copyright Related Articles

Research Article | Open Access

Volume 2022 | Article ID 8511601 | https://doi.org/10.1155/2022/8511601

Antibacterial Activity of Bismuth Oxide Nanoparticles Compared to Amikacin against Acinetobacter baumannii and Staphylococcus aureus

Kareem H. Jawad,¹Thorria R. Marzoog,²Buthenia A. Hasoon,²Ghassan M. Sulaiman,²Majid S. Jabir,²Elsadig M. Ahmed,^3,4and Khalil A. A. Khalil^3,5

Academic Editor: Rajeshkumar Shanmugam

Received27 Mar 2022

Revised06 Jun 2022

Accepted12 Jun 2022

Published01 Jul 2022

Abstract

In this work, bismuth oxide nanoparticles (Bi₂O₃ NP) were prepared by laser ablation of a solid target in distilled water. The optical and structural properties of Bi₂O₃ NPs were studied using UV–VIS spectroscopy, energy-dispersive X-ray spectroscopy (EDS), transmission electron microscope (TEM), scanning electron microscopy (SEM), and Fourier transform infrared (FTIR). The results showed that the average particle size is less than 20 nm. The antibacterial activity of the Bi₂O₃ NPs was determined and compared with amikacin against Acinetobacter baumannii and Staphylococcus aureus. The activity of Bi₂O₃ NPs was higher than the amikacin. Furthermore, the antibacterial activity of Bi₂O₃ NPs against S. aureus bacteria was higher than Acinetobacter baumannii; this result was confirmed by studying the effect of Bi₂O₃ NPs in bacterial biofilm formation in eyes contact lenses using atomic force microscopy (AFM) technique. Taken together, Bi₂O₃ NPs could be used as a preservative for contact lenses as eye drops to prevent the formation of microbial biofilms in contact lenses.

1. Introduction

Antibiotics are the primary foundation for the treatment of bacterial diseases. The medical community was convinced that the discovery of these antibiotics and their usage as chemotherapeutic agents would lead to the eradication of infectious diseases in the future. Antibiotic misuse, on the other hand, has become a major role in the development and spread of multidrug-resistant strains of various bacteria [1]. Microorganism keratitis, which is commonly associated with contact lenses, is a significant risk factor for the progression of microbial keratitis [2].

Many patients have bad clinical results unless aggressive and adequate treatments are initiated quickly [3]. Even if effectively handled, microbial keratitis may lead to corneal scarring and neovascularization, leading to a loss of core corneal clarity, requiring a corneal transplant to restore sight. Successful leadership can lead to a continuous loss of visual function and possibly even eye loss [4]. This situation forced researchers to look for new antimicrobial and anti-inflammatory substances from different sources, such as Bi₂O₃ NPs [5–7]. The growth of drug resistance, allergic reactions, and side effects has resulted in exploring alternative drugs for nosocomial infection treatment [8, 9]. Different researches have confirmed that the transitions in Bi₂O₃ are of the direct permissible type, and the width of the optical energy gap ranges between (2.80-2.95 eV). Bi₂O₃ is a crucial derivative in the fabrication of glass and ceramics, as also hydrocarbon oxidation catalysts. Sensors, microelectronics, and optical engineering are all frequent applications [7, 8]. Thus, it has a broad range of applications and may be used as a surface disinfectant in hospitals and the food, pharmaceutical, glass, and ceramic manufacturing industries [9].

The pulsed laser ablation technique is a simple, novel, nonpolluting, eco-friendly, low-cost, one-step, and quick method for producing pure metal nanoparticles with regular and minimum buildup [10–13]. The aim of this study was to synthesize Bi₂O₃ NPs by laser ablation technique and study their effect as a preservative of contact lenses against eye infections. The results showed the ability of Bi₂O₃ NPs as an antibacterial agent to prevent bacterial biofilm formation.

2. Materials and Methods

A pure plate of bismuth (Sigma Aldrich), contact lenses (Alcon-china), and DMSO was purchased from Sigma.

2.1. Preparation of Bi₂O₃ NPs

The Bi₂O₃-NPs were prepared via laser ablation of solids submerged in deionized distilled water [12, 14] as shown in the experiment illustrated in Figure 1. Then, the NPs were passed through a (0.22) m size filter for size uniformity by applying an Nd: YAG laser with a fundamental wavelength of (1064) nm., the target was irradiated for (15) min., using (150) pulses, a pulse length of (6) ns., a repetition rate of (2) Hz, spot size (10) mm, the focal length of the lens (8) cm, and the maximum output energy of (500) mJ.

2.2. Characterizations of Bi₂O₃ NPs

The formation of Bi₂O₃ NPs was achieved by measuring the solution’s absorption spectrum with a UV-vis (UV/Vis, Seoul, Korea) in the 200-800 nm range [12, 15]. The microstructure and particle size of the nanocrystals were determined from (SEM) images (INSPECTS50-USA) and analyzed using Image J software [16]. FTIR was measured on the functional groups present on the surface of Bi₂O₃ NPs prepared from the laser ablation method were sections made by KBr pellet method (Bruker Equinox55, Germany) in the wavenumber scope of (400–4000)cm-1 on (FTLA 2000-100) version [17]. TEM (Philips EM 208S) was used to evaluate the morphology of the nanoparticles and size distribution [18]. AFM was used to determine the beneficial groups and position of each atom on a three-dimensional diagram of the surface topography of a substance at the atomic level (CSPM-AA3000) [19]. EDS tests were done by (Inspect S 50/FEI Company/Netherlands). These assays were achieved at the University of Tehran.

2.3. Evaluation of MIC of Amikacin and Bi2O3 NPs

The microdilution assay determined the minimal inhibitory concentration (MIC) of amikacin and bismuth oxide NPs [20, 21].

2.4. Antibacterial Activity

The well diffusion technique was utilized to identify the antibacterial effects of amikacin and bismuth oxide NPs against Staphylococcus aureus and Acinetobacter baumannii isolates at the concentration for sub-MIC (32) μg/ml according to [22, 23].

2.5. Fluorescence-Activated Cell Sorting Assay

Bacterial strains were colored by applying the LIVE/DEAD BacLight Bacterial Viability kit corresponding to the production command (Invitrogen AG, Basel, Switzerland). The dilution of SYTO9 was (1 : 60) allowing for prior titrations to get to the best dilution of pigments to be utilized for stain, propidium iodide (PI) (equipment instructions). The samples remained kept for (30) min. at (4°C) and was analyzed by applying a flow cytometer assay (FCA). One unit cell was confined on the up-scatter (FSC-A) versus up-scatter height (FSC-H) plots. The cell remains were rejected. Consequently, 20000 incidents were established in the entry, particularly for single incidents. Unblemished and particular-color controllers were utilized to set a door for PI (+ve cells). FCA was achieved on a BD Verse method, Biosciences, U.S.A., and statistics were examined by applying FACS DIVA computer software (BD), San Jose, CA, U.S.A.

2.6. Effect of Sub-MIC of Amikacin and Bi₂O₃ NPs in Biofilm Formation in Contact Lenses Visualized by AFM

This assay was performed according to previous work, with a few changes to produce biofilm on contact lenses. Briefly, lenses were put in (10) ml of nutrient broth containing bacterial cell growth in a concentration of , which exhibited the highest reduction in biofilm formation capacity after treatment with NPs, and amikacin at sub-MIC was chosen for this experiment. For 24 hours, containers were incubated aerobically at (37°C). Decantation was used to remove the media and planktonic cells, followed by two washes with distilled water (DW). The adhering cells were allowed to dry for 30 minutes after being washed twice by DW. The lenses were then stained and prepared for examination under an atomic force microscope. Control positive was created by cultivating lenses with a bacterial culture free of NPs. At the same time, the control negative was prepared by cultivating lenses in nutrient broth without any treatment or bacteria.

2.7. Statistical Analysis

At a significance level of , an unpaired -test was used to evaluate the significance level in the observed values across the treatment groups [24].

3. Results and Discussion

3.1. Characteristics of Bi₂O₃ NPs

By decreasing bismuth ions in the solution, UV-visible spectroscopy verified the existence of nanoparticles (Figure 2). The Bi₂O₃ NPs were put in a quartz cuvette and monitored for wavelength scanning between (200 and 800) nm with distilled water as a reference. The absorption peak, which is typical of bismuth, was found at 245 nm.

SEM was used to examine the morphology of the produced Bi₂O₃NPs, as shown in Figure 3. The size distribution of the Bi₂O₃ NPs sample was evaluated using Image J software, and most of the particles were in the 22-24-30 nm range.

The infrared spectrum of the Bi₂O₃ NPs is shown in Figure 4. Four peaks appeared, with wavenumbers of 624.87 and 3455.67 cm⁻¹, which are attributed to variation group vibrations of -C=C-, C=O, S-H, and N-H groups. A broad peak at 624.87 cm⁻¹ is associated with an alkyne group (−C=C−), the peak at 1637.06 cm⁻¹ is associated with a carboxylic acid group, the peak at 2084.05 cm⁻¹ is related with the thiol group, and the peaks at 3455.67 cm⁻¹ are associated with amine groups.

TEM was used to evaluate the size distribution and morphology of nanoparticles. Figure 5(a) explains the TEM images of Bi₂O₃ nanoparticles are spherical-like shape, while Figure 5(b) shows histogram size distribution, most of the particles are in the 5–40 nm, and this was comparable with the SEM result. Figure 5(c) shows energy dispersive spectrum (EDS) explains the chemical composition of the as-synthesized Bi₂O₃NPs samples. The NPs are mainly composed of Bi and O atoms. The ratio of weight (%) of Bi and O in the as-prepared final NPs sample is 89.8 and 10.2, respectively.

(a)

(b)

(c)

The AFM images for the nanostructures deposited utilizing 150 pulses are shown in Figure 6. The topography of the surface of Bi₂O₃NPs particles was studied, and measurements of surface roughness, particle size nanoparticles rate, and particle size distribution were taken. The average surface roughness is 1.454 nm, with diameters ranging from 5 to 40 nm and a quasispherical shape. These findings are in good agreement with the TEM measurements.

(a)

(b)

(c)

3.2. Evaluation of MIC of Amikacin and Bi₂O₃ NPs

The MIC is used to identify which antibiotic class is the most effective. The MICs of amikacin and Bi₂O₃ NPs for S. aureus and A. baumannii isolate examined varied from 64 μg/ml in S. auras isolate, in A. baumannii isolate, and amikacin MICs 16 μg/ml. For S. aureus, the MIC of Bi₂O₃ NPs is 128 μg/ml (Table 1). Bi₂O₃NPs had MICs 64 μg/ml in A. baumannii isolate.

3.3. Antibiofilm Activity of Amikacin and Bi₂O₃ NPs

The well diffusion technique occurred used to investigate the synergistic impact of Bi₂O₃ NPs with antibiotics (Amikacin) at a concentration of 32 μg/ml. The synergistic impact of Bi₂O₃ NPs against S. aureus is shown in Figure 7. The inhibitory zones were (16) mm, followed by (13) mm for antibiotics alone and (23) mm for Bi₂O₃ NPs. In addition, Bi₂O₃ NPs with amikacin have a synergistic impact against A. baumannii. As seen in Figure 7, the zone of inhibition was (12) mm, followed by antibiotics alone (15) mm and Bi₂O₃NPs (20) mm. The interaction between antibiotics and nanoparticles is most likely to blame for this synergistic impact [25]. For example, silver nanoparticles and amoxicillin were shown to have the most significant synergistic impact in suppressing E. coli growth [26]. This showed that Bi₂O₃NPs might significantly enhance amikacin invasion and absorption into the cell membrane.

Furthermore, since NPs need a wide surface area for interactions, they have a higher bactericidal effect than bigger particles, increasing bacterial cytotoxicity. For the identical treatments, the inhibiting area in bacteria is larger as compared to bacteria. bacteria have a different cell wall structure than bacteria, which could explain why bacteria are more antibiotic-resistant. Only the exterior peptidoglycan layer of bacteria is present. bacteria, on the other hand, have an exterior polysaccharide barrier that keeps all polysaccharide structures intact [27]. Many active compounds, such as hydroxy and amido groups, are found in antibiotic compounds. Chelation is a simple reaction that these groups have with nanoparticles. Through van der Waals contact and other weak interactions, antibiotic molecules can connect. Finally, antimicrobial groups are formed, made up of a nanoparticle core and antibiotic molecules around it. Antimicrobial groups induce more destruction when they act on one location on the surface of bacterial cells [28].

3.4. Viability Assay for Bacterial Strains

Flow cytometry of microbial cells was also presented to confirm the bactericidal activity of the prepared nanoparticles. The stains which are applied in this research were SYTO9 and (PI) as DNA-binding pigments, depending on their cell-penetrative property. SYTO9 enters both live and dead cells as various to PI, which can only enter cells whose membrane integrity is conceded, as death/killing cells. The observed FCA is extra receptive compared with conventional plate analysis in the identification of death/killing bacterial cells as the failure in pathogenic cell penetrability is immediately found by PI integration. Unblemished cells as in Figure 8 were run to quantitate autofluorescence and set standard energy. At zero time, the experiments have been run to calculate the early proportion of PI (+ve cells). After 6 hr. of treatment with nanoparticles, the possibilities of these bacterial species were examined. Bi₂O₃NPs determined the maximum cell death ratio as studied by quantification of PI-positive cells as well as the nanoparticles as shown in Figure 8.

Flow cytometry of bacterial cells was also used to confirm the bactericidal activity of the nanostructured surfaces. SYTO9 and propidium iodide (PI), the DNA-binding dyes used in this investigation, have different cell-penetrating properties. SYTO9 can infiltrate both live and dead cells, whereas PI can only infiltrate cells whose membrane integrity has been disrupted, i.e., dead cells. It should be noted that the flow cytometric technique is more sensitive than standard plate assay in the detection of dead bacterial cells as the loss in bacterial cell permeability is readily detected by PI incorporation. Unstained cells (Figure 8) were run to quantitate autofluorescence and set baseline voltage. Samples were taken during the zeroth hour to determine the initial percentage of PI-positive cells. The viability of these cells was determined after 3 hours of exposure to nanomaterial samples. Quantification of PI-positive cells among nanostructured surfaces revealed that Bi₂O₃NPs had the highest cell death percentage (Figure 8).

3.5. Effect of Sub-MIC Amikacin and Bi₂O₃ NPs on Biofilm Formation Visualized by AFM

AFM also looked at the contact lenses to see how efficient amikacin and Bi₂O₃ NPs prevented biofilm development. As demonstrated in Figures 9(a)–9(g), Bi₂O₃ NPs outperformed amikacin in preventing biofilm development on the lenses. The results of an atomic force microscope (AFM) study of biofilm development in lenses with S. aureus bacteria was (29.6 nm) of high lens surface Figure 9(b). The outcome which did not have any bacteria was (2.14 nm) of lens surface in Figure 9(a). Figure 9(c) shows just A. baumannii bacteria or treatment on the high lens surface (21.4 nm). In Figure 9(d), the highest surface was (9.9 nm) with S. aureus and treated with amikacin antibiotic and with S. aureus and treated with Bi₂O₃ NPs (3.06 nm) in Figure 9(e). In Figure 9(f), the most significant surface was (12.4 nm) with A. baumannii and treated with Amikacin antibiotic. In comparison, the lowest surface was (8.06 nm) with A. baumannii and treated with Bi₂O₃ NPs in Figure 9(g). These findings revealed that Bi₂O₃ NPs were more effective as an antibiofilm agent than amikacin. AFM revealed no S. aureus colonization on any Bi₂O₃ NP-treated lenses (Figure 9(g)). On the other hand, the untreated contact lenses exhibited colonization of lenses as a multilayer on this lens contact Figure 9(a). AFM was used to measure the adhesion and biofilm stiffness [29]. Surface roughness [30] and topography have all been effective in microbial biofilm research [31]. A few studies have shown that Bi₂O₃ NPs have strong antibiofilm actions against various pathogens in vitro and have indicated various antibacterial mechanisms for Bi₂O₃ NPs, including impairing cell division, disturbing the cell wall cytoplasmic membrane, and decomposing DNA [32–34]. By employing AFM image analysis [29], the biofilm formation and surface roughness of P. aeruginosa were investigated by AFM.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

The production of harmful ions, shading impact on photosynthetic bacteria, cellular absorption of NPs, physical restraint and cell wall destruction, and oxidative stress are the key processes behind the toxicity of metallic-based nanoparticles, as shown by several biological models. Furthermore, the biological models are used to assess the potential hazards of nanomaterials (cell wall damage, inhibition of cell proliferation, gene expression changes, genotoxicity, and cell death, alteration of function and morphology of organelles, and the presence of oxidative stress bioindicators) [35]. Environmental nanotechnology is defined as the use of biotechnological applications as a low-cost, environmentally friendly, and simple method of producing, manipulating, and utilizing materials with dimensions ranging from 1 to 100 nm [36, 37]. Antimicrobial drug resistance in bacterial infection has driven the development of new treatment options. Among these efforts, nanomaterials have emerged as notable and novel antibacterial agents [38]. In this work, the effectiveness of bismuth nanoparticles in inhibiting the growth of A. baumannii and S. aureus was investigated using the broth microdilution method, which is a standard method that is more accurate, reliable, and easy to interpret than other methods such as the well diffusion method. Because of its poor water solubility, the inhibitory action of elemental bismuth can only be noticed at quite high doses. Nonetheless, our findings revealed that Bi₂O₃NPs had more efficient antibacterial action against A. baumannii and S. aureus than amikacin, with a MIC of bismuth nanoparticles that was higher than amikacin. Overall, the experimental data suggest that bismuth nanoparticles could be an interesting alternative to combat A. baumannii and S. aureus, which, given the benefits mentioned for bismuth nanoparticles such as inhibiting A. baumannii and S. aureus biofilm formation and higher antibacterial activity compared to amikacin, could be suggested for use in various fields of keratitis, which is commonly associated with contact. Furthermore, additional study is needed into the compatibility of nanoparticles with nature as well as the way of their recovery.

4. Conclusions

In this study, Bi₂O₃ NP was prepared by laser ablation technique. The antibacterial activity of the Bi₂O₃ NPs was determined and compared with amikacin against A. baumannii and S. aureus. S. aureus and A. baumannii, the predominantly bacterium of eye infection, displayed the different capabilities to create biofilms, Bi₂O₃ NP concentration of 32 μg/ml had antibacterial activity against S. aureus and A. baumannii. This result was confirmed by studying the effect of Bi₂O₃ NPs in bacterial biofilm formation in eyes contact lenses using the atomic force microscopy (AFM) technique. Taken together, Bi₂O₃ NPs could be used as a preservative for contact lenses as eye drops prevent the formation of microbial biofilms in contact lenses. Furthermore, Bi₂O₃ NPs were more effective as antibiofilm agents than amikacin in vitro by AFM, and the use of Bi₂O₃ NPs as contact lens preserving instead of chemicals preservatives. Taken together, Bi₂O₃ NPs could be used as promising therapeutic or preservative material for contact eye lenses to prevent the formation of microbial biofilms.

Data Availability

All data are presented within the article.

Conflicts of Interest

The authors report no conflicts of interest.

Acknowledgments

The authors thank their respective institutions for infrastructural supports. University of Technology, Baghdad, Iraq, and University of Bisha, Saudi Arabia, are thanked and gratefully acknowledged for their constant encouragement during the course of the study.

References

E. Tacconelli, E. Carrara, A. Savoldi et al., “Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis,” The Lancet Infectious Diseases, vol. 18, no. 3, pp. 318–327, 2018.
View at: Publisher Site | Google Scholar
Y. Hilliam, S. Kaye, and C. Winstanley, “Pseudomonas aeruginosa and microbial keratitis,” Journal of Medical Microbiology, vol. 69, no. 1, pp. 3–13, 2020.
View at: Publisher Site | Google Scholar
J. Mascarenhas, M. Srinivasan, M. Chen et al., “Differentiation of etiologic agents of bacterial keratitis from presentation characteristics,” International Ophthalmology, vol. 32, no. 6, pp. 531–538, 2012.
View at: Publisher Site | Google Scholar
H. Jin, W. T. Parker, N. W. Law et al., “Evolving risk factors and antibiotic sensitivity patterns for microbial keratitis at a large county hospital,” British Journal of Ophthalmology, vol. 101, no. 11, pp. 1483–1487, 2017.
View at: Publisher Site | Google Scholar
R. Vazquez-Munoz, M. J. Arellano-Jimenez, and J. L. Lopez-Ribot, “Bismuth nanoparticles obtained by a facile synthesis method exhibit antimicrobial activity against Staphylococcus aureus and Candida albicans,” BMC Biomedical Engineering, vol. 2, no. 1, pp. 11-12, 2020.
View at: Publisher Site | Google Scholar
M. Flores-Castañeda, A. L. Vega-Jiménez, A. Almaguer-Flores et al., “Antibacterial effect of bismuth subsalicylate nanoparticles synthesized by laser ablation,” Journal of Nanoparticle Research, vol. 17, no. 11, pp. 1–13, 2015.
View at: Publisher Site | Google Scholar
J. Z. Marinho, R. A. Silva, T. G. Barbosa, E. M. Richter, R. A. Muñoz, and R. C. Lima, “Graphite-composite electrodes bulk-modified with (BiO)2CO3 and Bi2O3 plates- like nanostructures for trace metal determination by anodic stripping voltammetry,” Electroanalysis, vol. 25, no. 3, pp. 765–770, 2013.
View at: Publisher Site | Google Scholar
S. Agarwal, G. Sharma, S. Dang, S. Gupta, and R. Gabrani, “Antimicrobial peptides as anti-infectives against Staphylococcus epidermidis,” Medical Principles and Practice, vol. 25, no. 4, pp. 301–308, 2016.
View at: Publisher Site | Google Scholar
A. Azad, S. Rostamifar, F. Modaresi, A. Bazrafkan, and Z. Rezaie, “Assessment of the antibacterial effects of bismuth nanoparticles against Enterococcus faecalis,” BioMed Research International, vol. 2020, Article ID 5465439, 2020.
View at: Publisher Site | Google Scholar
K. H. Jawad and B. A. Hasson, “Developing strategy for a successful antioxidant, anticancer activity via an improved method prepared to porous silicon nanoparticles,” Journal of Applied Sciences and Nanotechnology, vol. 1, no. 4, pp. 1–11, 2021.
View at: Publisher Site | Google Scholar
S. Amnah, R. I. Abd-Alrahman, and M. A. Mohammed, “Preparation of nanostructured HgI2 nanotubes/Si photodetector by laser ablation in liquid,” Silicon, 2021.
View at: Publisher Site | Google Scholar
K. H. Jawad, T. H. Saleh, and B. Abd-Alhamza, “Preparation of aluminum oxide nanoparticles by laser ablation and a study of their applications as antibacterial and wounds healing agent,” Nano Biomedicine and Engineering, vol. 11, no. 3, pp. 313–319, 2019.
View at: Publisher Site | Google Scholar
R. M. Altuwirqi, B. Baatiyah, E. Nugali, Z. Hashim, and H. Al-Jawhari, “Synthesis and characterization of aluminum nanoparticles prepared in vinegar using a pulsed laser ablation technique,” Journal of Nanomaterials, vol. 1155, Article ID 1327868, 2020.
View at: Publisher Site | Google Scholar
A. A. Menazea and N. S. Awwad, “Antibacterial activity of TiO₂ doped ZnO composite synthesized via laser ablation route for antimicrobial application,” Journal of Materials Research and Technology, vol. 9, no. 4, pp. 9434–9441, 2020.
View at: Publisher Site | Google Scholar
M. S. Jabir, U. M. Nayef, W. K. Abdulkadhim et al., “Fe₃O₄ nanoparticles capped with PEG induce apoptosis in breast cancer AMJ13 cells via mitochondrial damage and reduction of NF-κB translocation,” Journal of Inorganic and Organometallic Polymers, vol. 31, no. 3, pp. 1241–1259, 2021.
View at: Publisher Site | Google Scholar
R. A. Ismail, S. S. Shaker, and A. M. Mousa, “Study the optoelectronic properties of PbI₂ nanorods/Si photodetector prepared by magnetic field-assisted laser deposition route,” Optics and Laser Technology, vol. 140, article 107042, 2021.
View at: Publisher Site | Google Scholar
R. K. Maeh, A. I. Jaafar, B. A. A. H. Hasoon, and N. N. Hussein, “Preparation and characterization of graphene oxide for biological application,” Drug Invention Today, vol. 14, 2020.
View at: Google Scholar
H. H. Bahjat, R. A. Ismail, G. M. Sulaiman, and M. S. Jabir, “Magnetic field-assisted laser ablation of titanium dioxide nanoparticles in water for anti-bacterial applications,” Journal of Inorganic and Organometallic Polymers and Materials, vol. 31, no. 9, pp. 3649–3656, 2021.
View at: Publisher Site | Google Scholar
F. A. Fadhil, B. A. Hasoon, N. N. Hussein, and K. S. Khashan, “Preparation and characterization of CuO NPs via laser ablation under electric field and study their antibacterial activity,” AIP Conference Proceedings, vol. 2045, article 020002, 2018.
View at: Publisher Site | Google Scholar
CLSI, (Clinical and Laboratory Standards Institute), “The performance standard for antimicrobial susceptibility testing, twenty-first informational supplement,” M100-S21, vol. 31, no. 1, 2011.
View at: Google Scholar
N. N. Hussein, T. R. Marzoog, and A. E. Al-Niaame, “The antibacterial, antiheamolytic, and antioxidant activities of Laurus nobilis and Alhagi maurorum native to Iraq,” Baghdad Science Journal, vol. 16, 3(Suppl), pp. 707–712, 2019.
View at: Publisher Site | Google Scholar
M. G. Shehata, M. M. Abu-Serie, N. M. A. El-Aziz, and S. A. El-Sohaimy, “In vitro assessment of antioxidant, antimicrobial and anticancer properties of lactic acid bacteria,” International Journal of Pharmacology, vol. 15, no. 6, pp. 651–663, 2019.
View at: Publisher Site | Google Scholar
L. Ma, J. Wu, S. Wang, H. Yang, D. Liang, and Z. Lu, “Synergistic antibacterial effect of Bi₂S₃ nanospheres combined with ineffective antibiotic gentamicin against methicillin-resistant _Staphylococcus aureus_,” Journal of Inorganic Biochemistry, vol. 168, pp. 38–45, 2017.
View at: Publisher Site | Google Scholar
M. Varposhti, A. Abdi Ali, and P. Mohammadi, “Synergistic effects of bismuth thiols and various antibiotics against Pseudomonas aeruginosa biofilm,” Jundishapur Journal of Microbiology, vol. 7, no. 3, p. e9142, 2014.
View at: Publisher Site | Google Scholar
L. D. Geoffrion, D. Medina-Cruz, M. Kusper et al., “Bi2O3nano-flakes as a cost-effective antibacterial agent,” Nanoscale Advances, vol. 3, no. 14, pp. 4106–4118, 2021.
View at: Publisher Site | Google Scholar
S. A. Abid, A. A. Taha, R. A. Ismail, and M. H. Mohsin, “Antibacterial and cytotoxic activities of cerium oxide nanoparticles prepared by laser ablation in liquid,” Environmental Science and Pollution Research, vol. 27, no. 24, pp. 30479–30489, 2020.
View at: Publisher Site | Google Scholar
L. F. Dalvand, F. Hosseini, S. M. Dehaghi, and E. S. Torbati, “Inhibitory effect of bismuth oxide nanoparticles produced by bacillus licheniformis on methicillin-resistant Staphylococcus aureus strains (MRSA),” Iranian Journal of Biotechnology, vol. 16, no. 4, pp. 279–286, 2018.
View at: Publisher Site | Google Scholar
A. J. Talaei, N. Zarei, A. Hasan et al., “Fabrication of inorganic alumina particles at nanoscale by a pulsed laser ablation technique in liquid and exploring their protein binding, anticancer and antipathogenic activities,” Arabian Journal of Chemistry, vol. 14, no. 2, article 102923, 2021.
View at: Publisher Site | Google Scholar
L. P. Gonçalves, A. Miñán, G. Benítez et al., “Self-sterilizing ormosils surfaces based on photo-synzthesized silver nanoparticles,” Colloids and Surfaces B: Biointerfaces, vol. 164, pp. 144–154, 2018.
View at: Publisher Site | Google Scholar
M. C. Sportelli, E. Tuetuencue, R. A. Picca et al., “Inhibiting P. fluorescens biofilms with fluoropolymer-embedded silver nanoparticles: an in-situ spectroscopic study,” Scientific Reports, vol. 7, no. 1, pp. 1–13, 2017.
View at: Publisher Site | Google Scholar
S. M. Santos, J. M. Carbajo, N. Gómez, M. Ladero, and J. C. Villar, “Modification of bacterial cellulose biofilms with xylan polyelectrolytes,” Bioengineering, vol. 4, no. 4, p. 93, 2017.
View at: Publisher Site | Google Scholar
Z. Ni, X. Gu, Y. He et al., “Synthesis of silver nanoparticle-decorated hydroxyapatite (HA@ Ag) poriferous nanocomposites and the study of their antibacterial activities,” RSC Advances, vol. 8, no. 73, pp. 41722–41730, 2018.
View at: Publisher Site | Google Scholar
B. E. B. Al-Jumaili, Z. A. Talib, A. Zakaria et al., “Impact of ablation time on Cu oxide nanoparticle green synthesis via pulsed laser ablation in liquid media,” Applied Physics A, vol. 124, no. 9, pp. 1–6, 2018.
View at: Publisher Site | Google Scholar
A. Płaza, A. Kołodziej, J. Nizioł, and T. Ruman, “Laser ablation synthesis in solution and nebulization of silver-109 nanoparticles for mass spectrometry and mass spectrometry imaging,” ACS Measurement Science, vol. 2, no. 1, pp. 14–22, 2022.
View at: Publisher Site | Google Scholar
E. V. Soares and H. M. Soares, “Harmful effects of metal (loid) oxide nanoparticles,” Applied Microbiology and Biotechnology, vol. 105, no. 4, pp. 1379–1394, 2021.
View at: Publisher Site | Google Scholar
M. Saravanan, H. Barabadi, and H. Vahidi, “Green nanotechnology: isolation of bioactive molecules and modified approach of biosynthesis,” Biogenic Nanoparticles for Cancer Theranostics, Micro and Nano Technologies, pp. 101–122, 2021.
View at: Publisher Site | Google Scholar
H. Barabadi, H. Vahidi, K. Damavandi Kamali, M. Rashedi, and M. Saravanan, “Antineoplastic biogenic silver nanomaterials to combat cervical cancer: a novel approach in cancer therapeutics,” Journal of Cluster Science, vol. 31, no. 4, pp. 659–672, 2020.
View at: Publisher Site | Google Scholar
M. Saravanan, H. Barabadi, H. Vahidi et al., “Emerging Theranostic Silver and Gold Nanobiomaterials for Breast Cancer: Present Status and Future Prospects,” Handbook on Nanobiomaterials for Therapeutics and Diagnostic Applications, Elsevier, pp. 439–456, 2021.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2022 Kareem H. Jawad et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

1017

Downloads

520

Citations

Journal of Nanomaterials

Antibacterial Activity of Bismuth Oxide Nanoparticles Compared to Amikacin against Acinetobacter baumannii and Staphylococcus aureus

Abstract

1. Introduction

2. Materials and Methods

2.1. Preparation of Bi2O3 NPs

2.2. Characterizations of Bi2O3 NPs

2.3. Evaluation of MIC of Amikacin and Bi2O3 NPs

2.4. Antibacterial Activity

2.5. Fluorescence-Activated Cell Sorting Assay

2.6. Effect of Sub-MIC of Amikacin and Bi2O3 NPs in Biofilm Formation in Contact Lenses Visualized by AFM

2.7. Statistical Analysis

3. Results and Discussion

3.1. Characteristics of Bi2O3 NPs

3.2. Evaluation of MIC of Amikacin and Bi2O3 NPs

3.3. Antibiofilm Activity of Amikacin and Bi2O3 NPs

3.4. Viability Assay for Bacterial Strains

3.5. Effect of Sub-MIC Amikacin and Bi2O3 NPs on Biofilm Formation Visualized by AFM

4. Conclusions

Data Availability

Conflicts of Interest

Acknowledgments

References

Copyright

2.1. Preparation of Bi₂O₃ NPs

2.2. Characterizations of Bi₂O₃ NPs

2.6. Effect of Sub-MIC of Amikacin and Bi₂O₃ NPs in Biofilm Formation in Contact Lenses Visualized by AFM

3.1. Characteristics of Bi₂O₃ NPs

3.2. Evaluation of MIC of Amikacin and Bi₂O₃ NPs

3.3. Antibiofilm Activity of Amikacin and Bi₂O₃ NPs

3.5. Effect of Sub-MIC Amikacin and Bi₂O₃ NPs on Biofilm Formation Visualized by AFM